Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E - PubMed (original) (raw)
. 2001 Jan 5;276(1):261-6.
doi: 10.1074/jbc.M003324200.
Affiliations
- PMID: 11024044
- DOI: 10.1074/jbc.M003324200
Free article
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E
R K Tangirala et al. J Biol Chem. 2001.
Free article
Abstract
Apolipoprotein E is a multifunctional protein synthesized by hepatocytes and macrophages. Plasma apoE is largely liver-derived and known to regulate lipoprotein metabolism. Macrophage-derived apoE has been shown to reduce the progression of atherosclerosis in mice. We tested the hypothesis that liver-derived apoE could directly induce regression of pre-existing advanced atherosclerotic lesions without reducing plasma cholesterol levels. Aged low density lipoprotein (LDL) receptor-deficient (LDLR(-/-)) mice were fed a western-type diet for 14 weeks to induce advanced atherosclerotic lesions. One group of mice was sacrificed for evaluation of atherosclerosis at base line, and two other groups were injected with a second generation adenoviruses encoding human apoE3 or a control empty virus. Hepatic apoE gene transfer increased plasma apoE levels by 4-fold at 1 week, and apoE levels remained at least 2-fold higher than controls at 6 weeks. There were no significant changes in plasma total cholesterol levels or lipoprotein composition induced by expression of apoE. The liver-derived human apoE gained access to and was retained in arterial wall. Compared with base-line mice, the control group demonstrated progression of atherosclerosis; in contrast, hepatic apoE expression induced highly significant regression of advanced atherosclerotic lesions. Regression of lesions was accompanied by the loss of macrophage-derived foam cells and a trend toward increase in extracellular matrix of lesions. As an index of in vivo oxidant stress, we quantitated the isoprostane iPF(2 alpha)-VI and found that expression of apoE markedly reduced urinary, LDL-associated, and arterial wall iPF(2 alpha)-VI levels. In summary, these results demonstrate that liver-derived apoE directly induced regression of advanced atherosclerosis and has anti-oxidant properties in vivo that may contribute to its anti-atherogenic effects.
Similar articles
- Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
Tsukamoto K, Tangirala R, Chun SH, Puré E, Rader DJ. Tsukamoto K, et al. Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2162-70. doi: 10.1161/01.atv.19.9.2162. Arterioscler Thromb Vasc Biol. 1999. PMID: 10479659 - Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K, Tangirala RK, Chun S, Usher D, Puré E, Rader DJ. Tsukamoto K, et al. Mol Ther. 2000 Feb;1(2):189-94. doi: 10.1006/mthe.2000.0028. Mol Ther. 2000. PMID: 10933930 - Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ. Shi W, et al. Biochem Biophys Res Commun. 2004 Apr 23;317(1):223-9. doi: 10.1016/j.bbrc.2004.03.037. Biochem Biophys Res Commun. 2004. PMID: 15047172 - Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM, Withycombe S, Young SG. Véniant MM, et al. Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1567-70. doi: 10.1161/hq1001.097780. Arterioscler Thromb Vasc Biol. 2001. PMID: 11597927 Review. - Apolipoprotein E mimetics and cholesterol-lowering properties.
Sharifov OF, Nayyar G, Garber DW, Handattu SP, Mishra VK, Goldberg D, Anantharamaiah GM, Gupta H. Sharifov OF, et al. Am J Cardiovasc Drugs. 2011 Dec 1;11(6):371-81. doi: 10.2165/11594190-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 22149316 Review.
Cited by
- Dicarbonyl-modified lipoproteins contribute to proteinuric kidney injury.
Zhong J, Yang HC, Shelton EL, Matsusaka T, Clark AJ, Yermalitsky V, Mashhadi Z, May-Zhang LS, Linton MF, Fogo AB, Kirabo A, Davies SS, Kon V. Zhong J, et al. JCI Insight. 2022 Nov 8;7(21):e161878. doi: 10.1172/jci.insight.161878. JCI Insight. 2022. PMID: 36125905 Free PMC article. - Synthetic lipoproteins based on apolipoprotein E coupled to fullerenol have anti-atherosclerotic properties.
Tudorache IF, Bivol VG, Dumitrescu M, Fenyo IM, Simionescu M, Gafencu AV. Tudorache IF, et al. Pharmacol Rep. 2022 Aug;74(4):684-695. doi: 10.1007/s43440-022-00379-8. Epub 2022 Jul 5. Pharmacol Rep. 2022. PMID: 35790693 - Extracellular vesicles released by human retinal pigment epithelium mediate increased polarised secretion of drusen proteins in response to AMD stressors.
Flores-Bellver M, Mighty J, Aparicio-Domingo S, Li KV, Shi C, Zhou J, Cobb H, McGrath P, Michelis G, Lenhart P, Bilousova G, Heissel S, Rudy MJ, Coughlan C, Goodspeed AE, Becerra SP, Redenti S, Canto-Soler MV. Flores-Bellver M, et al. J Extracell Vesicles. 2021 Nov;10(13):e12165. doi: 10.1002/jev2.12165. J Extracell Vesicles. 2021. PMID: 34750957 Free PMC article. - Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice.
Tao H, Huang J, Yancey PG, Yermalitsky V, Blakemore JL, Zhang Y, Ding L, Zagol-Ikapitte I, Ye F, Amarnath V, Boutaud O, Oates JA, Roberts LJ 2nd, Davies SS, Linton MF. Tao H, et al. Nat Commun. 2020 Aug 14;11(1):4084. doi: 10.1038/s41467-020-17915-w. Nat Commun. 2020. PMID: 32796843 Free PMC article. - Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis.
Jiang Y, He T, Deng W, Sun P. Jiang Y, et al. Clin Interv Aging. 2017 Nov 13;12:1941-1949. doi: 10.2147/CIA.S143632. eCollection 2017. Clin Interv Aging. 2017. PMID: 29180857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous